About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

At the moment the company generates 15M USD in revenues.

On its last earning announcement, the company reported a loss of -0.31$ per share.

The book value per share is 0.43$

NovaBay Pharmaceuticals, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
15M 86.60% -6M -38.60% -4M -0.31 - - 17M 0.43 -7M - -7M